This inventor holds 17 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Isoflavonoid Compounds. Top assignees: Mei Pharma, Inc., Dendreon Corporation, Aardvark Therapeutic, Inc.. Active years: 2006-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Del Mar, CA (US) (2006)
- Hesperia, CA (US) (2010)
- Seattle, WA (US) (2013)
- Poway, CA (US) (2017 - 2023)
Company Filing History:
8 out of 33 
7 out of 53 
1 out of 1 Years Active: 2006-2025
Areas of Expertise:
Title: The Innovative Contributions of Ofir Moreno in Cancer Treatment
Introduction
Ofir Moreno is a notable inventor based in Poway, California, recognized for his significant contributions to the field of cancer treatment. With a total of eight patents to his name, he has made remarkable strides in the development of pharmaceutical compositions aimed at combatting cancer.
Latest Patents
Among his most recent innovations are two significant patents that focus on isoflavonoid compositions. The first patent titled "Isoflavonoid compositions and methods for the treatment of cancer" involves a pharmaceutical composition that includes an isoflavonoid derivative combined with cyclodextrin. This innovation also introduces methods for treating cancer, sensitizing cancer cells, and inducing apoptosis in malignancies through the administration of these compositions. Furthermore, it details specific intravenous compositions and therapies.
The second patent, "Isoflavonoid compounds and methods for the treatment of cancer," emphasizes a composition comprising at least one isoflavonoid, along with methods to treat cancer, enhance the sensitivity of cancer cells, and induce apoptosis. Both patents reflect Moreno's commitment to improving cancer therapeutics through innovative approaches.
Career Highlights
Ofir Moreno's career is marked by his role at Mei Pharma, Inc., where he has contributed extensively to pharmaceutical research and development. His expertise in the area of oncology and drug development has positioned him as a leading figure within the company, facilitating advancements in treatment methodologies.
Collaborations
Throughout his career, Moreno has collaborated with esteemed colleagues, including George Jeoffreys and Alison Johnson. These partnerships have fostered a collaborative environment that promotes innovative thinking and research, significantly enhancing the quality and impact of their work in the pharmaceutical industry.
Conclusion
Ofir Moreno's inventions and patents represent a crucial step forward in the treatment of cancer. His dedication to developing effective therapies underscores the importance of innovation in the biomedical field. With continued research and collaboration, Moreno is set to make even greater contributions to combating cancer and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile